A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback